Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy.

Acta ophthalmologica - 1 Jun 2022

Shimizu Yuichiro, Miyata Manabu, Ooto Sotaro, Miyake Masahiro, Mori Yuki, Tamura Hiroshi, Ueda-Arakawa Naoko, Uji Akihito, Muraoka Yuki, Takahashi Ayako, Wakazono Tomotaka, Yamashiro Kenji, Hata Masayuki, Tsujikawa Akitaka

Abstract excerpt

PURPOSE: To investigate whether the efficacy of anti-vascular endothelial growth factor (VEGF) monotherapy for polypoidal choroidal vasculopathy (PCV) differs between pachychoroid and non-pachychoroid phenotypes in the long term. METHODS: This retrospective longitudinal study included 115 treatment-naïve eyes in 115 consecutive patients with symptomatic PCV who were treated with anti-VEGF monotherapy and were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Choroid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Eye Diseases

Share to Fluorescein Angiography

Share to Intravitreal Injections

Share to Polyps

Share to Tomography, Optical Coherence

Share to Visual Acuity

Source

Identifiers

PMID: 34533280
DOI: 10.1111/aos.15015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy.PMID 34533280Read ↗

Differences between young and elderly polypoidal choroidal vasculopathy patients with and without pachychoroid phenotypes.Semantic proximity Read ↗

Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy representing Different Manifestations of the Same Spectrum in the Same Patient: A Case ReportSemantic proximity Read ↗

Ethnic Differences on Long Term Outcomes of Polypoidal Choroidal Vasculopathy after Predominantly Bevacizumab Monotherapy.Semantic proximity Read ↗

Pachychoroid Spectrum Disease: Underlying Pathology, Classification, and Phenotypes.Semantic proximity Read ↗

Polypoidal choroidal vasculopathy: clinical features and genetic predisposition.Semantic proximity Read ↗

Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic BackgroundsSemantic proximity Read ↗

Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?Semantic proximity Read ↗

Pachychoroid disease: review and updateSemantic proximity Read ↗

The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers.Semantic proximity Read ↗

Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy.Semantic proximity Read ↗

Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population.Semantic proximity Read ↗

Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.